Everest Medicines Market Cap

Everest Medicines has a market cap or net worth of 12.98 billion as of January 30, 2025. Its market cap has increased by 113.65% in one year.

Market Cap

12.98B

Enterprise Value

11.02B

Revenue

449.73M

Ranking

n/a

PE Ratio

n/a

Stock Price

40.30

Market Cap Chart

Since October 9, 2020, Everest Medicines's market cap has decreased from 20.64B to 12.98B, a decrease of -37.09%. That is a compound annual growth rate of -10.20%.

Market Cap History

Date	Market Cap	% Change
Jan 28, 2025	12.98B	-16.74%
Dec 31, 2024	15.59B	132.87%
Dec 29, 2023	6.70B	24.60%
Dec 30, 2022	5.37B	-47.96%
Dec 31, 2021	10.33B	-47.98%
Dec 31, 2020	19.85B	-3.81%

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
BeiGene	188.24B
Hansoh Pharmaceutical Group Company	106.11B
JD Health International	102.51B
WuXi Biologics	75.46B
Sinopharm Group	64.13B
Alibaba Health Information Technology	58.05B
Akeso	54.62B
Innovent Biologics	54.14B

Market Cap Rankings